Transcatheter patent foramen ovale closure using the Premere PFO occlusion system

Catheterization and Cardiovascular Interventions

Volumn 68, Issue 5, 2006, Pages 736-740

  Donti, Andrea ^a   Giardini, Alessandro ^a   Salomone, Luisa ^a   Formigari, Roberto ^a   Picchio, Fernando M ^a  

^a UNIVERSITY OF BOLOGNA   (Italy)

Author keywords

Coagulation; Congenital heart disease in adults; Patent foramen ovale

Indexed keywords

ACETYLSALICYLIC ACID; TICLOPIDINE; WARFARIN;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CRYPTOGENIC STROKE; DOPPLER ECHOGRAPHY; FEMALE; FLUOROSCOPY; FOLLOW UP; HEART ANEURYSM; HEART ATRIUM SEPTUM; HEART ATRIUM SEPTUM DEFECT; HUMAN; MALE; MIGRAINE AURA; RECURRENT DISEASE; SAFETY; STROKE; THROMBOPHILIA; TRANSESOPHAGEAL ECHOCARDIOGRAPHY; WOUND CLOSURE;

ADULT; CARDIAC SURGICAL PROCEDURES; ECHOCARDIOGRAPHY, DOPPLER; ECHOCARDIOGRAPHY, TRANSESOPHAGEAL; EQUIPMENT DESIGN; FEMALE; FOLLOW-UP STUDIES; HEART CATHETERIZATION; HEART SEPTAL DEFECTS, ATRIAL; HUMANS; ITALY; MALE; MIDDLE AGED; TREATMENT OUTCOME;

EID: 33750884692     PISSN: 15221946     EISSN: 1522726X     Source Type: Journal    
DOI: 10.1002/ccd.20845     Document Type: Article

References (20)

1. Lechat P, Mas JL, Lascault G, Loron P, Theard M, Klimczac M, Drobinski G, Thomas D, Grosgogeat Y. Prevalence of patent foramen ovale in patients with stroke. N Engl J Med 1988;318:1148-1152.
2. Di Tullio M, Sacco RL, Gopal A, Mohr JP, Homma S. Patent foramen ovale as a risk factor for cryptogenic stroke. Ann Intern Med 1992;117:461-465.
3. Anzola GP, Magoni M, Guindani M, Rozzini L, Dalla Volta G. Potential source of cerebral embolism in migraine with aura: A transcranial Doppler study. Neurology 1999;52:1622-1625.
4. Del Sette M, Angeli S, Leandri M, Ferriero G, Bruzzone GL, Finocchi C, Gandolfo C. Migraine with aura and right-to-left shunt on transcranial Doppler: A case-control study. Cerebrovasc Dis 1998;8:327-330.
5. Braun M, Gliech V, Boscheri A, Schoen S, Gahn G, Reichmann H, Haass M, Schraeder R, Strasser RH. Transcatheter closure of patent foramen ovale in patients with paradoxical embolism. Periprocedural safety and mid-term follow-up results of three different device occluder systems. Eur Heart J 2004;25:361-362.
6. Martin F, Sanchez PL, Doherty E, Colon-Hernandez PJ, Delgado G, Inglessis I, Scott N, Hung J, King ME, Buonanno F, Demirjian Z, de Moor M, Palacios IF. Percutaneous trasncatheter closure of patent foramen ovale in patients with paradoxical embolism. Circulation 2002;106:1034-1036.
7. Windecker S, Wahl A, Nedeltchev K, Arnold M, Schwerzmann M, Seiler C, Mattle HP, Meier B. Comparison of medical treatment with percutaneous closure of patent foramen ovale in patients with cryptogenic stroke. J Am Coll Cardiol 2004;44:750-758.
8. Braun MU, Fassbender D, Schoen SP, Haass M, Schraeder R, Scholtz W, Strasser RH. Transcatheter closure of patent foramen ovale in patients with cerebral ischemia. J Am Coll Cardiol 2002;39:2019-2025.
9. Bruch L, Parsi A, Grad MO, Rux S, Burmeister T, Krebs H, Kleber FX. Transcatheter closure of interatrial communications for secondary prevention of paradoxical embolism: Single-center experience. Circulation 2002;105:2845-2848.
10. Giardini A, Donti A, Formigari R, Bronzetti G, Prandstraller D, Bonvicini M, Palareti G, Guidetti D, Gaddi O, Picchio FM. Comparison of results of percutaneous closure of patent foramen ovale for paradoxical embolism in patients with versus without thrombophilia. Am J Cardiol 2004;94:1012-1016.
11. Windecker S, Wahl A, Chatterjee T, Garachemani A, Eberli FR, Seiler C, Meier B. Percutaneous closure of patent foramen ovale in patients with paradoxical embolism. Circulation 2000;101:893-898.
12. Giardini A, Donti A, Formigari R, Salomone L, Palareti G, Guidetti D, Picchio FM. Long-term efficacy of transcatheter patent foramen ovale closure on migraine headache with aura and recurrent stroke. Catheter Cardiovasc Interv 2006;67:625-629.
13. Krumsdorf U, Ostermayer S, Billinger K, Trepels T, Zadan E, Horvath K, Sievert H. Incidence and clinical course of thrombus formation on atrial septal defect and patent foramen ovale closure devices in 1,000 consecutive patients. J Am Coll Cardiol 2004;43:30230-30239.
14. Meier B. Closure of patent foramen ovale: Technique, pitfalls, complications, and follow up. Heart 2005;91:444-448.
15. Hara H, Virmani R, Ladich E, Mackey-Bojack S, Titus J, Reisman M, Gray W, Nakamura M, Mooney M, Poulose A, Schwartz RS. Patent foramen ovale: Current pathology, pathophysiology, and clinical status. J Am Coll Cardiol 2005;46:1768-1776.
16. Giardini A, Donti A, Formigari R, Salomone L, Prandstraller D, Bonvicini M, Palareti G, Guidetti D, Gaddi O, Picchio FM. Transcatheter patent foramen ovale closure mitigates aura migraine headaches abolishing spontaneous right-to-left shunting. Am Heart J 2006;151:922.
17. Hagen PT, Scholz DG, Edwards WD. Incidence and size of patent foramen ovale during the first 10 decades of life: An autopsy study of 965 normal hearts. Mayo Clin Proc 1984;59:17-20.
18. Marshall AC, Lock JE. Structural and compliant anatomy of the patent foramen ovale in patients undergoing transcatheter closure. Am Heart J 2000;140:303-307.
19. Ho SY, McCarthy KP, Rigby ML. Morphological features pertinent to interventional closure of patent oval foramen. J Interv Cardiol 2003;16:33-38.
20. Spencer MP, Moehring MA, Jesurum J, Gray WA, Olsen JV, Reisman M. Power m-mode transcranial Doppler for diagnosis of patent foramen ovale and assessing transcatheter closure. J Neuroimaging 2004;14:342-349.